• About us
  • Advertise
  • Contact
  • Nominate
  • Client’s Voice
  • Login
  • Register
📖 Magazine
The Global Economics
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
The Global Economics
No Result
View All Result
Home Infrastructure Healthcare

Variants Fuel Covid-19 Cases, Vaccine Makers on Their Toes

The mutations of COVID-19 and response of people to the vaccine will be propelling future inoculation

The Global Economics by The Global Economics
April 18, 2021
in Healthcare, Trending
Reading Time: 2 mins read
0
Variants Fuel Covid-19 Cases, Vaccine Makers on Their Toes

Variants Fuel Covid-19 Cases, Vaccine Makers on Their Toes

991
SHARES
5.5k
VIEWS
FacebookTwitterRedditWhatsAppLinkedInFacebook

The highly contagious variants of the coronavirus are fuelling the surge of fresh cases of COVID-19 leading to more lockdowns and rapid vaccination drive. 

Several vaccine makers are already testing new versions of their shots, tuned to the strains. Since the pandemic set in last year, the vaccine’s rollout has been affected by apprehensions and fears of people. 

The COVID-19 vaccine from Pfizer and BioNTech SE is seen to be highly effective six months after its second dose, with no serious safety concerns so far. The vaccine makes use of messenger RNA to carry genetic instructions to cells in the making of proteins. And the protection has remained stable across race, gender, age, ethnicity, and also with individuals with underlying health complications, as per the makers. 

As Johnson & Johnson had been expected to deliver over 50 million doses to European Union in the first quarter, there was a delay due to potential safety concerns. 

Last month, researchers in Norway and Germany said that the AstraZeneca-Oxford vaccine could trigger an autoimmune reaction in people causing blood clots despite the shot’s benefits exceeding potential health risks. Both AstraZeneca and J&J’s vaccines are based on similar technology—both use a modified common cold virus for carrying genetic instructions to human cells to produce spike protein located on the surface of coronavirus. 

Many health officials have started limiting the J&J vaccine for older people.

This recommended cessation has stirred a disruption in the mass vaccination campaign that is on the way to vaccinate as many people as possible before COVID-19 variants render the vaccines less effective. However, barring significant findings, the vaccines of AstraZeneca and J&J should return to shelves soon.

Tags: astrazenecabiontechcoronaCOVID-19GermanyJ&Jjohnson&johnsonlockdownnewversiomnorwaypfizerVaccine
The Global Economics

The Global Economics

The Global Economics Limited is a UK based financial publication and a bi-annual business magazine giving thoughful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

Related Posts

Evergrande Chairman Detained as Chinese Property Crisis Worsens
Real Estate

Evergrande Chairman Detained as Chinese Property Crisis Worsens

by The Global Economics
September 28, 2023
The US Entertainment Industry Strike Nears End as Writers and Studios Reach Deal
Lifestyle

The US Entertainment Industry Strike Nears End as Writers and Studios Reach Deal 

by The Global Economics
September 25, 2023
Japan Dumping Fukushima Waste Disrupts Asian Seafood Industry
Top Stories

Japan Dumping Fukushima Waste Disrupts Asian Seafood Industry

by The Global Economics
August 31, 2023
White House Touts ‘Bidenomics’ as the New Mantra for American Revival
Trending

White House Touts ‘Bidenomics’ as the New Mantra for American Revival

by The Global Economics
June 29, 2023
Saudi PIF Launches Lifera, a High-tech Biopharma Company
Healthcare

Saudi PIF Launches Lifera, a High-tech Biopharma Company 

by The Global Economics
June 19, 2023
Twitter Youtube LinkedIn Soundcloud
the global economics logo

The Global Economics Limited is a UK based financial publication and a quarterly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

DMCA.com Protection Status

  • Privacy
  • Legal
  • Terms of Use
  • Client’s Voice
  • Server Status

norton verified - the global economics

Latest Posts

Israel-Jordan-UAE Agree to Landmark Tripartite Water-for-Energy Deal

Israel-Jordan-UAE Agree to Landmark Tripartite Water-for-Energy Deal

September 29, 2023
Evergrande Chairman Detained as Chinese Property Crisis Worsens

Evergrande Chairman Detained as Chinese Property Crisis Worsens

September 28, 2023
Looming US Govt Shutdown & Bitter Political Divide Threatens Economy

Looming US Govt Shutdown & Bitter Political Divide Threatens Economy

September 27, 2023
Download The Global Economics PWA to your mobile or Desktop
PWA App Download
Download The Global Economics Android App to your mobile or Desktop
Android App
Download The Global Economics IOS App to your mobile or Desktop
IOS App

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

No Result
View All Result
  • About us
  • Awards
  • Magazine
  • Client’s Voice
  • Exclusive Coverage
  • Nominate
  • Login
  • Sign Up

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

Welcome Back!

Sign In with Facebook
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Linked In
OR

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version